🔥🐔 BizChicken 🐔🔥
Companies Similar to Biofrontera Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Evelo Biosciences, Inc.
EDP1815
Evelo Biosciences, Inc. discovers and develops oral biologics for inflammatory diseases and cancer, with key products like EDP1815 in clinical trials.
Symbol: EVLO
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 66
Address: 620 Memorial Drive, Cambridge, MA 02139
Phone: 617 577 0300
Last updated: 2024-12-31
Aura Biosciences, Inc.
AU-011
Aura Biosciences, Inc. operates as a biotechnology company developing virus-like drug conjugates (VDC) platform for treating ocular and urologic oncology tumors, with a focus on AU-011 for choroidal melanoma.
About | About | Management | Directors | About | Contact | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: AURA
Recent Price: $8.13
Industry: Biotechnology
CEO: Dr. Elisabet de los Pinos Ph.D.
Sector: Healthcare
Employees: 88
Address: 85 Bolton Street, Cambridge, MA 02140
Phone: 617 500 8864
Leadership
- David Johnson, Chairman
- Elisabet de los Pinos, PhD, Chief Executive Officer
- Giovanni Mariggi, PhD, Director
- Antony Mattessich, Director
- Sapna Srivastava, PhD, Director
- Karan Takhar, Director
Last updated: 2024-12-31
BioCryst Pharmaceuticals, Inc.
ORLADEYO
Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.
About | About | About | Contact | Careers | Careers | Safety | Jobs | Careers | About | About | About | About
Symbol: BCRX
Recent Price: $7.53
Industry: Biotechnology
CEO: Mr. Jon P. Stonehouse
Sector: Healthcare
Employees: 536
Address: 4505 Emperor Boulevard, Durham, NC 27703
Phone: 919 859 1302
Last updated: 2024-12-31
Biofrontera Inc.
Ameluz, Xepi, Rhodo LED lamp series
Biofrontera Inc. is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for dermatological conditions in the United States, including treatments for actinic keratosis and impetigo.
Symbol: BFRI
Recent Price: $1.11
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Hermann Luebbert Ph.D.
Sector: Healthcare
Employees: 83
Address: 120 Presidential Way, Woburn, MA 01801
Phone: 781 245 1325
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Biotricity, Inc.
Bioflux
Biotricity, Inc. is a medical technology company that provides biometric data monitoring solutions, focusing on remote monitoring solutions for medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions.
About | About | Contact | Contact | About | About | ESG | About | DEI | About | About | About | About | About | About
Symbol: BTCY
Recent Price: $0.25
Industry: Medical - Devices
CEO: Dr. Waqaas Al-Siddiq Ph.D.
Sector: Healthcare
Employees: 55
Address: 275 Shoreline Drive, Redwood City, CA 94065
Phone: 650 832 1626
Last updated: 2024-12-31
Clearside Biomedical, Inc.
XIPERE
Clearside Biomedical, Inc. is a biopharmaceutical company focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. They offer treatments such as XIPERE for uveitis macular edema and are developing additional therapies for ocular conditions.
Symbol: CLSD
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Sector: Healthcare
Employees: 30
Address: 900 North Point Parkway, Alpharetta, GA 30005
Phone: 678 270 3631
Last updated: 2024-12-31
Chimerix, Inc.
TEMBEXA (brincidofovir)
Chimerix, Inc. is a biopharmaceutical company that develops medicines to enhance the lives of patients with serious diseases, including smallpox and various tumors.
Leadership | Contact | Contact | Careers | Jobs | Jobs | About | Leadership
Symbol: CMRX
Recent Price: $3.44
Industry: Biotechnology
CEO: Mr. Michael T. Andriole M.B.A.
Sector: Healthcare
Employees: 72
Address: 2505 Meridian Parkway, Durham, NC 27713
Phone: 919 806 1074
Leadership
- Mike Andriole, President, CEO
- Joshua E. Allen, PhD, Chief Scientific Officer
- Michael A. Alrutz, JD, PhD, Senior Vice President and General Counsel
- Michelle LaSpaluto, Chief Financial Officer
- Allen Melemed, MD, MBA, Chief Medical Officer
- Tom Riga, Chief Operating and Commercial Officer
- Roy W. Ware, PhD, MBA, Chief Manufacturing Technology Officer
- Caryn Barnett, Vice President Clinical Operations
- Tom Brundage, Vice President Biostatistics
- David Jakeman, VP Accounting and Finance
- Christopher Jordan, Vice President Regulatory Affairs
- Pablo Lee, Vice President Medical Affairs
- Odin Naderer, PharmD, Vice President Clinical Pharmacology and Translational Medicine
- Mike Sherman, Chairman
- Martha J. Demski, Lead Independent Director
- Lisa Decker, PhD,
- Marc D. Kozin,
- Robert J. Meyer, MD,
- Fred A. Middleton,
- Pratik S. Multani, MD,
- Vicki Vakiener,
Last updated: 2024-12-31
Journey Medical Corporation
Qbrexza, Accutane, Targadox, Ximino, Exelderm
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for treating dermatological conditions in the United States. It offers various products for hyperhidrosis and acne treatment and more.
Symbol: DERM
Recent Price: $3.97
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Claude Maraoui
Sector: Healthcare
Employees: 41
Address: 9237 East Via de Ventura Boulevard, Scottsdale, AZ 85258
Phone: 480 434 6670
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Fortress Biotech, Inc.
Pharmaceutical and Biotechnology Products
Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.
About | About | About | Leadership | Directors | About | About | Contact | Careers | Careers | Careers | About | About | About
Symbol: FBIO
Recent Price: $2.18
Industry: Biotechnology
CEO: Dr. Lindsay Allan Rosenwald
Sector: Healthcare
Employees: 186
Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154
Phone: 781 652 4500
Leadership
- Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
- Michael S. Weiss, Executive Vice Chairman, Strategic Development
- David Jin, Chief Financial Officer and Head of Corporate Development
- George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
- Samuel Berry, General Counsel and Corporate Secretary
- Jimmie Harvey, Jr., M.D., Director
- Malcolm Hoenlein, Director
- Dov Klein, Director
- J. Jay Lobell, Director
- Kevin L. Lorenz, J.D., Director
- Lucy Lu, M.D., Director
Last updated: 2024-12-31
FibroGen, Inc.
Roxadustat, Pamrevlumab
Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.
Symbol: FGEN
Recent Price: $0.53
Industry: Biotechnology
CEO: Mr. Thane Wettig
Sector: Healthcare
Employees: 486
Address: 409 Illinois Street, San Francisco, CA 94158
Phone: 415 978 1200
Last updated: 2024-12-31
Lantern Pharma Inc.
LP-100
Lantern Pharma Inc. is a clinical stage biotechnology company focused on using artificial intelligence, machine learning, and genomic data to streamline drug development, with key drug candidates including LP-100, LP-300, and LP-184 for various cancer treatments.
About | About | About | About | Contact | About | Careers | Careers | About | About | About | About | About | About | About | About | About
Symbol: LTRN
Recent Price: $3.27
Industry: Biotechnology
CEO: Mr. Panna Sharma PH.D.
Sector: Healthcare
Employees: 21
Address: 1920 McKinney Avenue, Dallas, TX 75201
Phone: 972 277 1136
Last updated: 2024-12-31
Lumos Pharma, Inc.
LUM-201
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for rare diseases, with its lead candidate LUM-201 in a Phase 2 trial for pediatric growth hormone deficiency.
Symbol: LUMO
Recent Price: $4.34
Industry: Biotechnology
CEO: Mr. Richard J. Hawkins
Sector: Healthcare
Employees: 33
Address: 4200 Marathon Boulevard, Austin, TX 78756
Phone: 512 215 2630
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31
Nektar Therapeutics
Bempegaldesleukin
Nektar Therapeutics is a biopharmaceutical company focused on developing medicines for unmet medical needs. Their products include Bempegaldesleukin, an IL-2 pathway agonist in clinical trials for various cancers and COVID-19, and NKTR-358, a cytokine Treg stimulant for autoimmune diseases.
About | Our Story | Leadership | Directors | About | Locations | Contact | Contact | Careers | Jobs | DEI | Careers | Careers | DEI | Careers | Careers | Jobs | Jobs | About | About
Symbol: NKTR
Recent Price: $0.94
Industry: Biotechnology
CEO: Mr. Howard W. Robin
Sector: Healthcare
Employees: 137
Address: 455 Mission Bay Boulevard South, San Francisco, CA 94158
Phone: 415 482 5300
Leadership
- Howard W. Robin, President & Chief Executive Officer
- Robert Bacci, Senior Vice President, HR and Facilities Operations
- Sandra Gardiner, Chief Financial Officer
- Jennifer Ruddock, Chief Business Officer
- Mary Tagliaferri, M.D., Chief Medical Officer
- Mark A. Wilson, Chief Legal Officer
- Jonathan Zalevsky, Ph.D., Chief Research & Development Officer
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
SCYNEXIS, Inc.
BREXAFEMME (ibrexafungerp tablets)
SCYNEXIS, Inc. is a biotechnology company focused on developing products for the treatment of fungal infections. They offer BREXAFEMME for the treatment of vulvovaginal candidiasis and are developing Ibrexafungerp, an oral and intravenous drug for various fungal infections.
Symbol: SCYX
Recent Price: $1.07
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. David Gonzalez Angulo M.D.
Sector: Healthcare
Employees: 29
Address: 1 Evertrust Plaza, Jersey City, NJ 07302-6548
Phone: 201 884 5485
Leadership
- Armando Anido, Director
- Steven C. Gilman, Ph.D., Director
- David Angulo, M.D., President and Chief Executive Officer
- Scott Sukenick, Chief Legal Officer
- Ivor Macleod, MBA, CPA, Chief Financial Officer
- Daniella Gigante, Vice President, Human Resources and Information Technology
- Rossana Ferrara-Pontoriero, Ph.D., Vice President, Business Development and Alliance Management
- Guy Macdonald, Chairman of the Board
- Ann F. Hanham, Ph.D., Director
- David Hastings, Director
- Philippe Tinmouth, Director
Last updated: 2024-12-31